Lene Hammer-Helmich

Lene Hammer-Helmich is Head of Global Strategic Evidence & Communications at LEO Pharma, where she leads the development and execution of evidence generation and dissemination strategies for priority assets. Her work focuses on integrating cross-functional evidence gaps, building strategic evidence plans, and orchestrating evidence generation across the product lifecycle to strengthen scientific value and support informed decision-making.

Prior to joining LEO Pharma, Lene spent more than 10 years at Lundbeck, most recently as Director and Head of Real World Evidence and Epidemiology. She led global RWE strategy across brain health products, generating evidence on disease burden, patient profiles, treatment outcomes, and product effectiveness and safety in routine clinical practice. Lene brings extensive expertise in observational research, digital RWE, advanced analytics, and translating evidence into strategic value across development and commercialization.